Search results for "ddc:610"

showing 10 items of 435 documents

The val158met polymorphism of human catechol-O-methyltransferase (COMT) affects anterior cingulate cortex activation in response to painful laser sti…

2010

Background: Pain is a complex experience with sensory, emotional and cognitive aspects. Genetic and environmental factors contribute to pain-related phenotypes such as chronic pain states. Genetic variations in the gene coding for catechol-O-methyltransferase ( COMT) have been suggested to affect clinical and experimental pain-related phenotypes including regional μ-opioid system responses to painful stimulation as measured by ligand-PET (positron emission tomography). The functional val158met single nucleotide polymorphism has been most widely studied. However, apart from its impact on pain-induced opioid release the effect of this genetic variation on cerebral pain processing has not been…

AdultMaleGenotypePainSingle-nucleotide polymorphismStimulationCatechol O-MethyltransferaseGyrus CinguliCellular and Molecular NeuroscienceYoung Adultmedicinelcsh:PathologyHumansddc:610AlleleAnterior cingulate cortexCerebral CortexCatechol-O-methyl transferasePolymorphism Geneticmedicine.diagnostic_testResearchLasersChronic painMiddle Agedmedicine.diseaseMagnetic Resonance ImagingAnesthesiology and Pain Medicinemedicine.anatomical_structureCerebral cortexPositron-Emission TomographyMolecular MedicineFemaleFunctional magnetic resonance imagingPsychologyNeurosciencelcsh:RB1-214Molecular Pain
researchProduct

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

2020

ObjectiveTo determine the prevalence of antibodies to Epstein-Barr virus (EBV) in a large cohort of patients with early multiple sclerosis (MS).MethodsSerum samples were collected from 901 patients with a clinically isolated syndrome (CIS) or early relapsing–remitting multiple sclerosis (RRMS) participating in the German National MS cohort, a prospective cohort of patients with early MS with stringent inclusion criteria. Epstein-Barr nuclear antigen (EBNA)-1 and viral capsid antigen (VCA) antibodies were measured in diluted sera by chemiluminescence immunoassays (CLIAs). Sera of EBNA-1 and VCA antibody-negative patients were retested undiluted by an EBV IgG immunoblot. For comparison, we re…

AdultMaleHerpesvirus 4 HumanMultiple Sclerosis610 Medicine & healthmedicine.disease_causeAntibodies ViralSerology03 medical and health sciences0302 clinical medicineAntigenSeroepidemiologic Studieshemic and lymphatic diseasesGermanymedicineSeroprevalenceHumans1506Registriesddc:610Prospective cohort study610 Medicine & health030304 developmental biologyRetrospective Studies0303 health sciencesClinically isolated syndromebusiness.industryMultiple sclerosisMiddle Agedmedicine.diseaseEpstein–Barr virusddc:Psychiatry and Mental healthImmunologyCohortSurgeryFemaleNeurology (clinical)Function and Dysfunction of the Nervous Systembusiness030217 neurology & neurosurgery
researchProduct

Reliability, validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with social phobia

2013

Abstract Objective The aim of the study was to analyse the psychometric properties of the EQ-5D in patients with social phobia. Methods We used a sample of 445 patients with social phobia with five measurement points over a 30 month period. The discriminative ability of the EQ-5D was analysed by comparing the patients’ responses with the general population and between different disease severity levels. For test-retest reliability we assessed the level of agreement in patients’ responses over time, when there was no change in the Liebowitz Social Anxiety Scale (LSAS). Construct validity was analysed by identifying correlations of the EQ-5D with more specific instruments. For responsiveness w…

AdultMaleIntraclass correlationHealth StatusPopulationLiebowitz social anxiety scaleValidityPhobic disorderYoung Adult03 medical and health sciences0302 clinical medicineEQ-5DGermanySurveys and QuestionnairesmedicineHumansddc:610030212 general & internal medicineeducationeducation.field_of_studyResearchEQ-5DPublic Health Environmental and Occupational HealthBeck Depression InventoryReproducibility of ResultsConstruct validityResponsivenessGeneral MedicineMiddle AgedReliability030227 psychiatryPhobic DisordersQuality of LifeAnxietyFemalemedicine.symptomSocial phobiaPsychologyClinical psychology
researchProduct

Functional polymorphism in the neuropeptide Y gene promoter (rs16147) is associated with serum leptin levels and waist-hip ratio in women

2013

<b><i>Objective:</i></b> The neuropeptide-Y (NP-Y) gene is a strong candidate gene in the pathophysiology of obesity-linked behavior, and several single-nucleotide polymorphisms of NP-Y have already been linked to body weight and appetite. However, the results from current studies remain inconclusive. The aim of the present study was to test whether a certain functional genetic variant (SNP rs16147) in the NP-Y promoter gene is associated with serum leptin levels and body fat distribution. <b><i>Method:</i></b> We genotyped and measured the serum leptin levels of the NP-Y rs16147 polymorphism in 1,097 Caucasian subjects in the context of a pop…

AdultMaleLeptinCandidate genemedicine.medical_specialtyGenotypeblood [Leptin]Medicine (miscellaneous)610 Medicine & healthmacromolecular substancesPolymorphism Single NucleotideWhite PeopleStatistics NonparametricWaist–hip ratiogenetics [Obesity]Sex FactorsMedizinische FakultätInternal medicineGenotypemedicineHumansNeuropeptide YObesityddc:610Genephysiology [Neuropeptide Y]Nutrition and Dieteticsbusiness.industryWaist-Hip RatioLeptinCase-control study2701 Medicine (miscellaneous)Middle AgedNeuropeptide Y receptormedicine.diseaseObesitygenetics [European Continental Ancestry Group]EndocrinologyCase-Control Studies10054 Clinic for Psychiatry Psychotherapy and Psychosomatics2916 Nutrition and DieteticsFemalegenetics [Neuropeptide Y]businessphysiology [Polymorphism Single Nucleotide]
researchProduct

Genome-wide association data provide further support for an association between 5-HTTLPR and major depressive disorder.

2013

Abstract Background Dysfunctions of serotonergic neurotransmission are supposed to be involved in the pathogenesis of psychiatric disorders such as major depressive disorder (MDD). The concentration of serotonin (5-hydroxytryptamine, 5-HT) in the synaptic cleft is essentially regulated by the 5-HT transporter (5-HTT). A length polymorphism repeat in the 5-HTT promoter region, termed 5-HTTLPR, has been commonly investigated for an association with psychiatric disorders. Methods Genotyping of the 5-HTTLPR is time-consuming and technically challenging. Recently, a two-SNP haplotype was identified that tags the 5-HTTLPR at r 2 =0.775. This allows extraction of 5-HTTLPR genotype information from…

AdultMaleLinkage disequilibriumSynaptic cleftGenotypeSingle-nucleotide polymorphismGenome-wide association studyPolymorphism Single NucleotideGermanygenetics [Haplotypes]mental disordersGenotypegenetics [Serotonin Plasma Membrane Transport Proteins]medicineHumansGenetic Predisposition to Diseaseddc:610GeneticsSerotonin Plasma Membrane Transport ProteinsDepressive Disorder MajorSLC6A4 protein humanHaplotypegenetics [Depressive Disorder Major]Middle Agedmedicine.diseasePsychiatry and Mental healthClinical PsychologyHaplotypes5-HTTLPRCase-Control Studiesgenetics [Polymorphism Single Nucleotide]Major depressive disorderFemalePsychologyClinical psychologyGenome-Wide Association StudyJournal of affective disorders
researchProduct

Prevalence of Musculoskeletal Disorders among Dentists and Dental Students in Germany

2020

Background: Dentists are at a higher risk of suffering from musculoskeletal disorders (MSD) than the general population. However, the latest study investigating MSD in the dental profession in Germany was published about 20 years ago. Therefore, the aim of this study was to reveal the current prevalence of MSD in dentists and dental students in Germany. Methods: The final study size contained 450 (287 f/163 m) subjects of different areas of specialization. The age of the participants ranged from 23 to 75 years. The questionnaire consisted of a modified version of the Nordic Questionnaire, work-related questions from the latest questionnaire of German dentists, typical medical conditions and…

AdultMaleMusculoskeletal painmedicine.medical_specialtyShouldersHealth Toxicology and MutagenesisprevalencePopulationStudents Dentallcsh:MedicineDental educationArticleYoung AdultMSD03 medical and health sciences0302 clinical medicineRisk FactorsGermanySurveys and QuestionnairesHumansMedicineddc:610Musculoskeletal Diseases030212 general & internal medicineNordic questionnaireeducationmusculoskeletal painAgededucation.field_of_studybusiness.industrylcsh:RPublic Health Environmental and Occupational Healthdental profession030206 dentistryMiddle AgedOccupational Diseasesdental educationPhysical therapyFemaleBody regiondentistsbusinessInternational Journal of Environmental Research and Public Health
researchProduct

Association Study of Nonsynonymous Single Nucleotide Polymorphisms in Schizophrenia

2010

Genome-wide association studies using several hundred thousand anonymous markers present limited statistical power. Alternatively, association studies restricted to common nonsynonymous single nucleotide polymorphisms (nsSNPs) have the advantage of strongly reducing the multiple testing problem, while increasing the probability of testing functional single nucleotide polymorphisms (SNPs).We performed a case-control association study of common nsSNPs in Galician (northwest Spain) samples using the Affymetrix GeneChip Human 20k cSNP Kit, followed by a replication study of the more promising results. After quality control procedures, the discovery sample consisted of 5100 nsSNPs at minor allel…

AdultMaleNonsynonymous substitutionGenotype"psychosis"methods [Genetic Association Studies]"mental brain homeostasis"Single-nucleotide polymorphismBiologygenetics [Cation Transport Proteins]Polymorphism Single Nucleotide03 medical and health sciences0302 clinical medicineHumansGenetic Predisposition to Diseasegenetics [Schizophrenia]ddc:610statistics & numerical data [Genetic Association Studies]genetics [Genetic Predisposition to Disease]Cation Transport ProteinsGenetic Association StudiesBiological PsychiatryAged030304 developmental biology"ZIP8"Aged 80 and overGenetics0303 health sciences"mental brain homeostasis"; "psychosis"; "metal ion transporters"; "ZIP8"; "whole-genome assosiation"; "SLC39A3"Zip8 protein humanMiddle Aged3. Good health"whole-genome assosiation"SpainCase-Control StudiesSchizophreniaFemale"SLC39A3""metal ion transporters"030217 neurology & neurosurgeryBiological Psychiatry
researchProduct

Pre-Emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia after Transplantation

2016

Abstract Monitoring of minimal residual disease (MRD) or chimerism may help guide pre-emptive immunotherapy (IT) with a view to preventing relapse in childhood acute lymphoblastic leukemia (ALL) after transplantation. Patients with ALL who consecutively underwent transplantation in Frankfurt/Main, Germany between January 1, 2005 and July 1, 2014 were included in this retrospective study. Chimerism monitoring was performed in all, and MRD assessment was performed in 58 of 89 patients. IT was guided in 19 of 24 patients with mixed chimerism (MC) and MRD and by MRD only in another 4 patients with complete chimerism (CC). The 3-year probabilities of event-free survival (EFS) were .69 ± .06 for …

AdultMaleOncologymedicine.medical_specialtyNeoplasm ResidualAdolescentmedicine.medical_treatmenteducationDiseaseRelapse preventionChimerismYoung Adult03 medical and health sciences0302 clinical medicineRecurrenceGermanyInternal medicineSecondary PreventionHumansTransplantation HomologousMedicineddc:610ChildChildhood Acute Lymphoblastic LeukemiaImmunosuppression TherapyTransplantationbusiness.industryHematopoietic Stem Cell TransplantationRetrospective cohort studyHematologyImmunotherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisMinimal residual diseaseSurgeryTransplantationChild PreschoolLymphocyte Transfusion030220 oncology & carcinogenesisCohortFemaleImmunotherapybusiness030215 immunologyBiology of Blood and Marrow Transplantation
researchProduct

Bovine pericardium based non-cross linked collagen matrix for successful root coverage, a clinical study in human

2012

Abstract Introduction The aim of this study was to clinically assess the capacity of a novel bovine pericardium based, non-cross linked collagen matrix in root coverage. Methods 62 gingival recessions of Miller class I or II were treated. The matrix was adapted underneath a coronal repositioned split thickness flap. Clinical values were assessed at baseline and after six months. Results The mean recession in each patient was 2.2 mm at baseline. 6 Months after surgery 86.7% of the exposed root surfaces were covered. On average 0,3 mm of recession remained. The clinical attachment level changed from 3.5 ± 1.3 mm to 1,8 ( ± 0,7) mm during the observational time period. No statistically signifi…

AdultMalePathologymedicine.medical_specialtylcsh:Specialties of internal medicineBovine pericardiumClinical NeurologyConnective tissueMatrix (biology)Gingival recessionClinical studylcsh:RC581-951medicineAnimalsHumansroot coverageddc:610Tooth RootGeneral Dentistryconnective tissueTissue Scaffoldsbusiness.industryDentistry(all)Researchguided tissue regenerationAnatomycollagen matrixMiddle Agedbovine pericardiumRoot coveragemedicine.anatomical_structureOtorhinolaryngologycardiovascular systemHead and neck surgeryGuided Tissue Regeneration PeriodontalCattleFemaleNeurology (clinical)CollagenbusinessPericardiumHead & Face Medicine
researchProduct

Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks

2019

Background For the prevention of attacks of hereditary angioedema (HAE), the efficacy and safety of subcutaneous human C1-esterase inhibitor (C1-INH[SC]; HAEGARDA, CSL Behring) was established in the 16-week Clinical Study for Optimal Management of Preventing Angioedema with Low-Volume Subcutaneous C1-Inhibitor Replacement Therapy (COMPACT). Objective To assess the long-term safety, occurrence of angioedema attacks, and use of rescue medication with C1-INH(SC). Methods Open-label, randomized, parallel-arm extension of COMPACT across 11 countries. Patients with frequent angioedema attacks, either study treatment-naive or who had completed COMPACT, were randomly assigned (1:1) to 40 IU/kg or …

AdultMalePediatricsmedicine.medical_specialtyAdolescentInjections SubcutaneousAttack rateC1-inhibitor03 medical and health sciencesYoung Adult0302 clinical medicinemedicineLong term outcomesImmunology and AllergyHumans030212 general & internal medicineddc:610Adverse effectChildAgedbiologyAngioedemabusiness.industryIncidence (epidemiology)Angioedemas HereditaryMiddle Agedmedicine.diseaseOptimal managementTreatment Outcome030228 respiratory systemHereditary angioedemabiology.proteinFemalemedicine.symptombusinessComplement C1 Inhibitor Protein
researchProduct